Continuous glucose monitoring (CGM) devices provide real-time glucose monitoring and timely alerts for glycemic excursions, improving glycemic control among patients with diabetes. However, identifying rare events like hypoglycemia and hyperglycemia remain challenging due to their infrequency. Moreover, limited access to sensitive patient data hampers the development of robust machine learning models. Our objective is to accurately predict glycemic excursions while addressing data privacy concerns. To tackle excursion prediction, we propose a novel Hypo-Hyper (HH) loss function, which significantly improves performance in the glycemic excursion regions. The HH loss function demonstrates a 46% improvement over mean-squared error (MSE) loss across 125 patients. To address privacy concerns, we propose FedGlu, a machine learning model trained in a federated learning (FL) framework. FL allows collaborative learning without sharing sensitive data by training models locally and sharing only model parameters across other patients. FedGlu achieves a 35% superior glycemic excursion detection rate compared to local models. This improvement translates to enhanced performance in predicting both, hypoglycemia and hyperglycemia, for 105 out of 125 patients. These results underscore the effectiveness of the proposed HH loss function in augmenting the predictive capabilities of glucose predictions. Moreover, implementing models within a federated learning framework not only ensures better predictive capabilities but also safeguards sensitive data concurrently.

Prostate cancer is a commonly diagnosed cancerous disease among men world-wide. Even with modern technology such as multi-parametric magnetic resonance tomography and guided biopsies, the process for diagnosing prostate cancer remains time consuming and requires highly trained professionals. In this paper, different convolutional neural networks (CNN) are evaluated on their abilities to reliably classify whether an MRI sequence contains malignant lesions. Implementations of a ResNet, a ConvNet and a ConvNeXt for 3D image data are trained and evaluated. The models are trained using different data augmentation techniques, learning rates, and optimizers. The data is taken from a private dataset, provided by Cantonal Hospital Aarau. The best result was achieved by a ResNet3D, yielding an average precision score of 0.4583 and AUC ROC score of 0.6214.

This document provides responses to the FDA's request for public comments (Docket No FDA 2023 N 4853) on the role of digital health technologies (DHTs) in detecting prediabetes and undiagnosed type 2 diabetes. It explores current DHT applications in prevention, detection, treatment and reversal of prediabetes, highlighting AI chatbots, online forums, wearables and mobile apps. The methods employed by DHTs to capture health signals like glucose, diet, symptoms and community insights are outlined. Key subpopulations that could benefit most from remote screening tools include rural residents, minority groups, high-risk individuals and those with limited healthcare access. Capturable high-impact risk factors encompass glycemic variability, cardiovascular parameters, respiratory health, blood biomarkers and patient reported symptoms. An array of non-invasive monitoring tools are discussed, although further research into their accuracy for diverse groups is warranted. Extensive health datasets providing immense opportunities for AI and ML based risk modeling are presented. Promising techniques leveraging EHRs, imaging, wearables and surveys to enhance screening through AI and ML algorithms are showcased. Analysis of social media and streaming data further allows disease prediction across populations. Ongoing innovation focused on inclusivity and accessibility is highlighted as pivotal in unlocking DHTs potential for transforming prediabetes and diabetes prevention and care.

BioBERT and BioMegatron are Transformers models adapted for the biomedical domain based on publicly available biomedical corpora. As such, they have the potential to encode large-scale biological knowledge. We investigate the encoding and representation of biological knowledge in these models, and its potential utility to support inference in cancer precision medicine - namely, the interpretation of the clinical significance of genomic alterations. We compare the performance of different transformer baselines; we use probing to determine the consistency of encodings for distinct entities; and we use clustering methods to compare and contrast the internal properties of the embeddings for genes, variants, drugs and diseases. We show that these models do indeed encode biological knowledge, although some of this is lost in fine-tuning for specific tasks. Finally, we analyse how the models behave with regard to biases and imbalances in the dataset.

While current research has shown the importance of Multi-parametric MRI (mpMRI) in diagnosing prostate cancer (PCa), further investigation is needed for how to incorporate the specific structures of the mpMRI data, such as the regional heterogeneity and between-voxel correlation within a subject. This paper proposes a machine learning-based method for improved voxel-wise PCa classification by taking into account the unique structures of the data. We propose a multi-resolution modeling approach to account for regional heterogeneity, where base learners trained locally at multiple resolutions are combined using the super learner, and account for between-voxel correlation by efficient spatial Gaussian kernel smoothing. The method is flexible in that the super learner framework allows implementation of any classifier as the base learner, and can be easily extended to classifying cancer into more sub-categories. We describe detailed classification algorithm for the binary PCa status, as well as the ordinal clinical significance of PCa for which a weighted likelihood approach is implemented to enhance the detection of the less prevalent cancer categories. We illustrate the advantages of the proposed approach over conventional modeling and machine learning approaches through simulations and application to in vivo data.

Equally impressive to their algorithm's performance is their effort to validate their technique with images from multiple institutions, addressing the challenge of generalizability that many machine learning–based diagnostics face.2 However, their work raises a fundamental question that should be considered as algorithms begin to perform tasks that could previously be performed only by clinicians. Is the algorithm being asked to perform exactly the same task as its human counterpart? This question has important implications for evaluating the relative performance of the algorithm as well as for assessing the clinical significance of its findings. Initially, it appears that the algorithm and the radiologists are given the same task: to identify ENE in lymph nodes from CT scans.

Non-synonymous single nucleotide polymorphisms (nsSNPs) are single nucleotide substitution occurring in the coding region of a gene and leads to a change in amino-acid sequence of protein. The studies have shown these variations may be associated with disease. Thus, investigating the effects of nsSNPs on protein function will give a greater insight on how nsSNPs can lead into disease. Breast cancer is the most common cancer among women causing highest cancer death every year. BRCA1 and BRCA2 tumor suppressor genes are two main candidates of which, mutations in them can increase the risk of developing breast cancer. For prediction and detection of the cancer one can use experimental or computational methods, but the experimental method is very costly and time consuming in comparison with the computational method. The computer and computational methods have been used for more than 30 years. Here we try to predict the clinical significance of BRCA1 and BRCA2 nsSNPs as well as the unknown clinical significances. Nearly 500 BRCA1 and BRCA2 nsSNPs with known clinical significances retrieved from NCBI database. Based on hydrophobicity or hydrophilicity and their role in proteins' second structure, they are divided into 6 groups, each assigned with scores. The data are prepared in the acceptable form to the automated prediction mechanisms, Probabilistic Neural Network (PNN) and Deep Neural NetworkStacked AutoEncoder (DNN). With Jackknife cross validation we show that the prediction accuracy achieved for BRCA1 and BRCA2 using PNN are 87.97% and 82.17% respectively, while 95.41% and 92.80% accuracies achieved using DNN. The total required processing time for the training and testing the PNN is 0.9 second and DNN requires about 7 hours of training and it can predict instantly. both methods show great improvement in accuracy and speed compared to previous attempts.

Each year in the United States, more than 40,000 people die by suicide, and from 1999 to 2014, the suicide rate increased 24 percent. You might think that after generations of theories and data, we would be close to understanding how to prevent self-harm, or at least predict it. But a new study concludes that the science of suicide prediction is dismal, and the established warning signs about as accurate as tea leaves. There is, however, some hope. New research shows that machine-learning algorithms can dramatically improve our predictive abilities on suicides.

Each year in the United States, more than 40,000 people die by suicide, and from 1999 to 2014, the suicide rate increased 24 percent. You might think that after generations of theories and data, we would be close to understanding how to prevent self-harm, or at least predict it. But a new study concludes that the science of suicide prediction is dismal, and the established warning signs about as accurate as tea leaves. There is, however, some hope. New research shows that machine-learning algorithms can dramatically improve our predictive abilities on suicides.

Each year in the United States, more than 40,000 people die by suicide, and from 1999 to 2014, the suicide rate increased 24 percent. You might think that after generations of theories and data, we would be close to understanding how to prevent self-harm, or at least predict it. But a new study concludes that the science of suicide prediction is dismal, and the established warning signs about as accurate as tea leaves. There is, however, some hope. New research shows that machine-learning algorithms can dramatically improve our predictive abilities on suicides.